P. Kleinbauernschmitt et al., IMPROVED EFFICACY OF CHEMOTHERAPY BY PARVOVIRUS-MEDIATED SENSITIZATION OF HUMAN TUMOR-CELLS, European journal of cancer, 32A(10), 1996, pp. 1774-1780
Increasing resistance of tumour cells towards the cytotoxic action of
chemotherapeutic drugs is a major limitation in the treatment of cance
r patients. The non-pathogenic human adeno-associated viruses (AAV) ha
ve been reported to sensitise HeLa cervical cancer cells to gamma irra
diation in vivo and in vitro. To test whether these parvoviruses might
render other human tumour cells more sensitive towards chemotherapeut
ic drugs, we analysed the effects of AAV type 2 (AAV-2) infection on e
stablished cancer cell lines and freshly explanted tumour biopsies tre
ated with chemotherapeutic agents (e.g. cisplatin). AAV-2 infection si
gnificantly increased the cytotoxic activity of chemotherapeutic drugs
compared with uninfected controls. AAV-2 infection without concomitan
t chemotherapeutic treatment had no significant effect on viability of
the cells. In nude mice, combined application of AAV-2 infection and
chemotherapeutic treatment significantly increased the therapeutic act
ivity on tumours arising from subcutaneously injected tumour cells com
pared with tumours treated by chemotherapeutics only. These results in
dicate that AAV-2 infection sensitises human cancer cells towards the
cytotoxic action of chemotherapeutic drugs. Copyright (C) 1996 Elsevie
r Science Ltd